Constructive Disruption with the JCF Editors
Priya and Michael chat with the editors of the Journal of Cardiac Failure (JCF) about what constructive disruption to scientific publishing means, touching on broad inclusion, double-blind peer reviews within seven days, being a platform for critical documents that help to define the field, mentorship, and what’s on the horizon for the JCF.
Listen below and subscribe: Apple Podcasts, Google Podcasts, Spotify, Podcast Home
Hosts:
-
Michael Beasley, MD, Assistant Professor of Medicine at the Yale School of Medicine @MHBeasleyMD
-
Priya Umapathi, MD, Assistant Professor in the Division of Cardiology & Advanced Heart Failure and Heart Transplant Cardiologist at Johns Hopkins Hospital @priyaumapathi
Guests:
-
Anuradha Lala-Trindade (Anu Lala), MD, Deputy Editor, Journal of Cardiac Failure, Associate Professor of Medicine, Mount Sinai Hospital
-
Robert J. Mentz, MD, Editor-in-Chief, Journal of Cardiac Failure, Chief, Heart Failure Section, Duke University
Guest Disclosures
Dr. Robert J. Mentz received research support and honoraria from Abbott, American Regent, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Fast BioMedical, Gilead, Innolife, Eli Lilly, Medtronic, Medable, Merck, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Relypsa, Respicardia, Roche, Rocket Pharmaceuticals, Sanofi, Verily, Vifor, Windtree Therapeutics, and Zoll.